MediWound Ltd (NASDAQ: MDWD) has reported a loss for its first fiscal quarter (ending March 31) of $-1.05 versus a loss $-0.44 for the same period a year ago. For the latest four quarters through March 31, E.P.S. were $-1.38 compared to $-3.44 a year ago.
Recent Price Action
On 5/29/24, MediWound Ltd (NASDAQ: MDWD) stock suffered a major decline of -10.0%, closing at $16.01. Moreover, unusually high trading volume at 155% of normal accompanied the decline. The stock has declined -7.6% during the last week but has been exceptionally strong relative to the market over the last nine months.
Current PriceTarget Research Rating
With future capital returns forecasted to be in line with the cost of capital, MDWD is expected to be Value Creation neutral.
MediWound has a current Value Trend Rating of C (Low Neutral). The Value Trend Rating reflects very contradictory signals from PTR’s two proprietary measures of a stock’s attractiveness. MediWound has a very low Appreciation Score of 5 but a very high Power Rating of 89, with the Low Neutral Value Trend Rating the result.
Rating Review
In light of this new information and highly negative price change we are reviewing our current Overall Rating of C. This review will be completed in the next several days.
Be the first to comment